Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The FDA has accredited Zynyz as a first-line therapy in superior anal most cancers.The US Meals and Drug Administration (FDA) has accredited first-line...
Dr. Daniel Petrylak highlights the significance of early detection and evolving therapies for bladder most cancers throughout Bladder Most cancers Consciousness Month.The month...
Robotic and minimally invasive surgical procedure for kidney most cancers could result in much less blood loss, shorter hospital stays, lowered ache and...
